NDC product
BUPRENORPHINE AND NALOXONE
NDC 0781-7249 · Indivior Inc.
Key facts
| Product NDC | 0781-7249 |
|---|---|
| Proprietary name | BUPRENORPHINE AND NALOXONE |
| Labeler | Indivior Inc. |
| Marketing category | NDA AUTHORIZED GENERIC |
| Application number | NDA022410 |
| Marketing start | Feb 19, 2019 |
| Marketing end | Apr 30, 2021 |
| Listing certified through | Apr 30, 2021 |
At a glance
- 1–9 Package NDCs
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About National Drug Codes (NDC)
The National Drug Code (NDC) is the FDA's product identifier for drugs; the product NDC identifies the labeler and product, and each package adds a package code.
Source: U.S. Food and Drug Administration (FDA), National Drug Code Directory · Source date: